$OPCH
Option Care Health, Inc.

2020 Q2 Form 10-Q Financial Statement

#000101473920000026 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $740.8M $497.3M
YoY Change 48.98% 3.71%
Cost Of Revenue $574.5M $126.9M
YoY Change 352.87% 9.52%
Gross Profit $166.3M $101.4M
YoY Change 64.04% 0.11%
Gross Profit Margin 22.45% 20.39%
Selling, General & Admin $124.9M $99.25M
YoY Change 25.87% 810.5%
% of Gross Profit 75.11% 97.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.19M $10.15M
YoY Change 79.25% 59.44%
% of Gross Profit 10.94% 10.01%
Operating Expenses $143.1M $109.4M
YoY Change 30.82% 88.02%
Operating Profit $23.21M -$8.005M
YoY Change -389.92% -189.97%
Interest Expense $31.43M $11.56M
YoY Change 171.83% -183.76%
% of Operating Profit 135.44%
Other Income/Expense, Net $14.00K -$20.91M
YoY Change -100.07% 24.02%
Pretax Income -$7.200M -$14.01M
YoY Change -48.62% -7.09%
Income Tax $500.0K -$5.400M
% Of Pretax Income
Net Earnings -$7.668M -$13.60M
YoY Change -43.63% 215.69%
Net Earnings / Revenue -1.04% -2.74%
Basic Earnings Per Share -$0.04 -$0.10
Diluted Earnings Per Share -$0.04 -$0.10
COMMON SHARES
Basic Shares Outstanding 176.7M shares 128.8M shares
Diluted Shares Outstanding 176.7M shares 128.8M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.1M $14.40M
YoY Change 720.14% -30.77%
Cash & Equivalents $118.1M $14.39M
Short-Term Investments
Other Short-Term Assets $50.10M $17.30M
YoY Change 189.6% 27.21%
Inventory $149.1M $27.80M
Prepaid Expenses
Receivables $320.2M $118.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $637.5M $177.6M
YoY Change 258.9% 13.47%
LONG-TERM ASSETS
Property, Plant & Equipment $117.6M $27.10M
YoY Change 334.01% 8.39%
Goodwill $1.429B $632.5M
YoY Change 125.88% 0.81%
Intangibles
YoY Change
Long-Term Investments $18.00M
YoY Change
Other Assets $21.88M $1.679M
YoY Change 1202.92% -20.05%
Total Long-Term Assets $1.989B $422.9M
YoY Change 370.22% 3.26%
TOTAL ASSETS
Total Short-Term Assets $637.5M $177.6M
Total Long-Term Assets $1.989B $422.9M
Total Assets $2.626B $600.6M
YoY Change 337.29% 6.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $260.1M $73.37M
YoY Change 254.55% 48.93%
Accrued Expenses $125.2M $36.30M
YoY Change 244.9% 21.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $9.250M $5.900M
YoY Change 56.78% 490.0%
Total Short-Term Liabilities $394.6M $116.2M
YoY Change 239.7% 41.39%
LONG-TERM LIABILITIES
Long-Term Debt $1.275B $519.4M
YoY Change 145.55% 5.5%
Other Long-Term Liabilities $34.78M $21.01M
YoY Change 65.56% -0.67%
Total Long-Term Liabilities $1.364B $21.01M
YoY Change 6390.97% -0.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $394.6M $116.2M
Total Long-Term Liabilities $1.364B $21.01M
Total Liabilities $1.758B $675.8M
YoY Change 160.18% 13.46%
SHAREHOLDERS EQUITY
Retained Earnings -$119.5M -$787.2M
YoY Change -84.81% 6.71%
Common Stock $1.009B $614.3M
YoY Change 64.26% -1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.403M $1.722M
YoY Change 39.55% 426.61%
Treasury Stock Shares 383.7K shares 663.8K shares
Shareholders Equity $868.0M $584.1M
YoY Change
Total Liabilities & Shareholders Equity $2.626B $600.6M
YoY Change 337.29% 6.08%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$7.668M -$13.60M
YoY Change -43.63% 215.69%
Depreciation, Depletion And Amortization $18.19M $10.15M
YoY Change 79.25% 59.44%
Cash From Operating Activities $35.00M $13.30M
YoY Change 163.16% -188.08%
INVESTING ACTIVITIES
Capital Expenditures -$3.900M -$3.100M
YoY Change 25.81% -27.91%
Acquisitions
YoY Change
Other Investing Activities $500.0K $0.00
YoY Change
Cash From Investing Activities -$3.300M -$3.200M
YoY Change 3.12% -25.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.300M -1.100M
YoY Change -945.45% -111.11%
NET CHANGE
Cash From Operating Activities 35.00M 13.30M
Cash From Investing Activities -3.300M -3.200M
Cash From Financing Activities 9.300M -1.100M
Net Change In Cash 41.00M 9.000M
YoY Change 355.56% -194.74%
FREE CASH FLOW
Cash From Operating Activities $35.00M $13.30M
Capital Expenditures -$3.900M -$3.100M
Free Cash Flow $38.90M $16.40M
YoY Change 137.2% -251.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001014739
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-11993
dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N,
dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn,
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
940-2443
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
OPCH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
186716364 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118099000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67056000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
320222000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
324416000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
149115000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
115876000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50107000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51306000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
637543000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
558654000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117629000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133198000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52126000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63502000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
368481000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
385910000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1428610000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1425542000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21876000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22741000 USD
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1988722000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2030893000 USD
CY2020Q2 us-gaap Assets
Assets
2626265000 USD
CY2019Q4 us-gaap Assets
Assets
2589547000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
260120000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
221060000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47742000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
45765000 USD
CY2020Q2 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
59027000 USD
CY2019Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
33538000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18472000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20391000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
394611000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
330004000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1275385000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1277246000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50779000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58242000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2741000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2143000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34783000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15085000 USD
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1363688000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1352716000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1758299000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1682720000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
177098513 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176714791 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176975628 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176591907 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1009135000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1008362000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119533000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91955000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19251000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7195000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
867966000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
906827000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2626265000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2589547000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
740848000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
497266000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1446288000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
973758000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
574528000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
395876000 USD
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10150000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1121939000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
774174000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
166320000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
101390000 USD
us-gaap Gross Profit
GrossProfit
324349000 USD
us-gaap Gross Profit
GrossProfit
199584000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124918000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
99245000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
254198000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
182032000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18194000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38295000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20119000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
143112000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
109395000 USD
us-gaap Operating Expenses
OperatingExpenses
292493000 USD
us-gaap Operating Expenses
OperatingExpenses
202151000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23208000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8005000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31856000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2567000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
31432000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
11563000 USD
us-gaap Interest Expense
InterestExpense
59519000 USD
us-gaap Interest Expense
InterestExpense
22608000 USD
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1012000 USD
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
643000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1574000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1192000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-101000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-177000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-30406000 USD
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11021000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-57923000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21593000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-7198000 USD
CY2019Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-19026000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-26067000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-24160000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
470000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5423000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1511000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6845000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7668000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-13603000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27578000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17315000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
15000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-227000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4576000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
27000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-12056000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-478000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4576000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12056000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-478000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3092000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13576000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39634000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17793000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176711000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176686000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
us-gaap Net Income Loss
NetIncomeLoss
-27578000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17315000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
41813000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21591000 USD
bios Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
11240000 USD
bios Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
6182000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
598000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7912000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2764000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1635000 USD
bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
3746000 USD
bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1574000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1192000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1418000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1153000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-769000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
61000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4194000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-26050000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33239000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8321000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1199000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6527000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
36422000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-18692000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1977000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7338000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
13767000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
7609000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9382000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
5442000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-6794000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-1168000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53390000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22406000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9269000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8502000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-541000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-636000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8728000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7866000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
645000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
4625000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
2076000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
11651000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6381000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4076000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51043000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10464000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67056000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36391000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118099000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46855000 USD
us-gaap Interest Paid Net
InterestPaidNet
53199000 USD
us-gaap Interest Paid Net
InterestPaidNet
15156000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1887000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1060000 USD
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
13388000 USD
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
9299000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
602825000 USD
CY2019Q1 bios Interest On Management Notes Receivable
InterestOnManagementNotesReceivable
21000 USD
CY2019Q1 bios Adjustments To Additional Paid In Capital Stockholders Redemption
AdjustmentsToAdditionalPaidInCapitalStockholdersRedemption
2000000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
584000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3712000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-505000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
597171000 USD
CY2019Q2 bios Interest On Management Notes Receivable
InterestOnManagementNotesReceivable
18000 USD
CY2019Q2 bios Adjustments To Additional Paid In Capital Stockholders Redemption
AdjustmentsToAdditionalPaidInCapitalStockholdersRedemption
0 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
569000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-13603000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
584146000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
906827000 USD
CY2020Q1 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
549000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
757000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-19910000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-16632000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
870493000 USD
CY2020Q2 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
96000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
661000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7668000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4576000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
867966000 USD
CY2020Q2 bios Grant Funds Cares Act
GrantFundsCARESAct
11700000 USD
CY2020Q2 bios Grant Funds Cares Act
GrantFundsCARESAct
11700000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
740848000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
497266000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1446288000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
973758000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.065
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.058
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6800000 USD
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.285
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7668000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
CY2020Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
700000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000 USD
CY2019Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-13603000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27578000 USD
us-gaap Net Income Loss
NetIncomeLoss
-17315000 USD
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176711000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
176686000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
7600000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
15300000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
5600000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
10800000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0548
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
19591000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14192000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10774000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8009000 USD
CY2020Q2 bios Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
18328000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11895000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82789000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13538000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
69251000 USD
CY2020Q2 bios Operating Leases Not Yet Commenced Number Of Leases
OperatingLeasesNotYetCommencedNumberOfLeases
1 numberOfLeases
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P15Y
CY2020Q2 bios Lessee Operating Lease Lease Not Yet Commenced Future Minimum Payments Due
LesseeOperatingLeaseLeaseNotYetCommencedFutureMinimumPaymentsDue
22900000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
202912000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
211820000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85283000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78622000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117629000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133198000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
11159000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
5946000 USD
us-gaap Depreciation
Depreciation
24220000 USD
us-gaap Depreciation
Depreciation
11799000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1425542000 USD
CY2020Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2341000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
1427883000 USD
CY2020Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
727000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1428610000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
483059000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
483059000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
114578000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
97149000 USD
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
368481000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
385910000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17600000 USD
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9800000 USD
CY2020Q2 bios Number Of Equity Method Investments
NumberOfEquityMethodInvestments
2 investment
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
18000000.0 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17000000.0 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000.0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1600000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
600000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1200000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1332631000 USD
CY2020Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
19105000 USD
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
28891000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1284635000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1275385000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1337256000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20071000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
30689000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1286496000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1277246000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4625000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
9250000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9250000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
9250000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9250000 USD
CY2020Q2 bios Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1291006000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1332631000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
42000 USD
CY2020Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
23018000 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
7285000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
4576000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-12056000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-705000 USD
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7156000 USD
CY2019Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-103000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8190000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-286000 USD
CY2020Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
16600000 USD

Files In Submission

Name View Source Status
0001014739-20-000026-index-headers.html Edgar Link pending
0001014739-20-000026-index.html Edgar Link pending
0001014739-20-000026.txt Edgar Link pending
0001014739-20-000026-xbrl.zip Edgar Link pending
bios-20200630.htm Edgar Link pending
bios-20200630.xsd Edgar Link pending
bios-20200630_cal.xml Edgar Link unprocessable
bios-20200630_def.xml Edgar Link unprocessable
bios-20200630_g1.jpg Edgar Link pending
bios-20200630_htm.xml Edgar Link completed
bios-20200630_lab.xml Edgar Link unprocessable
bios-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex311x20200630x10q.htm Edgar Link pending
opch-ex312x20200630x10q.htm Edgar Link pending
opch-ex321x20200630x10q.htm Edgar Link pending
opch-ex322x20200630x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending